Search Menu
Photonics Media Photonics Buyers' Guide Photonics EDU Photonics Spectra BioPhotonics EuroPhotonics Industrial Photonics Photonics Showcase Photonics ProdSpec Photonics Handbook
More News
Email Facebook Twitter Google+ LinkedIn Comments

AbD Serotec

Jan 2009
AbD Serotec of Martinsried, Germany, and e2v biosensors of Chelmsford, UK, have launched a research program to perform feasibility studies showing proof of concept of the British company’s Visucare biosensor system. The system, a detection technology for biomarkers that uses a single-antibody immunoassay, will be used for protein quantification in point-of-care and near-patient testing.

AbD SerotecBiophotonicsdetection technologye2v biosensorsNews & FeaturesSensors & Detectors

Terms & Conditions Privacy Policy About Us Contact Us
back to top

Facebook Twitter Instagram LinkedIn YouTube RSS
©2018 Photonics Media, 100 West St., Pittsfield, MA, 01201 USA,
x Subscribe to BioPhotonics magazine - FREE!